Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Plos One
|
March 11, 2015
Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner
Arjun Seth, Fiona K Ritchie, Nani Wibowo, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
November 5, 2016
Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?
Ali Razaghi, Emilyn Tan, Linda H L Lua, et al.
Methods (San Diego, Calif.)
|
May 4, 2013
Virus-like particle formulation optimization by miniaturized high-throughput screening
Johannes Mohr, Yap P Chuan, Yang Wu, et al.
Vaccine
|
April 16, 2018
Vaccine Technology VI: Innovative and integrated approaches in vaccine development
Laura A Palomares, Tarit K Mukhopadhyay, Yvonne Genzel, et al.
Vaccine
|
September 27, 2015
Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza
Nani Wibowo, Yang Wu, Yuanyuan Fan, et al.
Biotechnology Progress
|
July 12, 2022
Design and optimization of membrane chromatography for monoclonal antibody charge variant separation
Sathish Nadar, Balaji Somasundaram, Marcela Charry, et al.
Vaccine
|
May 6, 2014
Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation
Nani Wibowo, Yap P Chuan, Arjun Seth, et al.
Biotechnology and Bioengineering
|
October 23, 2010
A new bioproduction route for a novel antimicrobial peptide
Derrick Kok Sing Tay, Gobinath Rajagopalan, Xiang Li, et al.
Chemico-Biological Interactions
|
September 2, 2024
Effective parallel evaluation of molecular design, expression and bioactivity of novel recombinant butyrylcholinesterase medical countermeasures
Joanne L Allard, Miguel Aguirre, Ruchi Gupta, et al.
Experimental & Applied Acarology
|
July 29, 2017
Evaluation of three adjuvants with respect to both adverse effects and the efficacy of antibody production to the Bm86 protein
Julie Petermann, Romain Bonnefond, Isabelle Mermoud, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Plos One
|
March 11, 2015
Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner
Arjun Seth, Fiona K Ritchie, Nani Wibowo, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
November 5, 2016
Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?
Ali Razaghi, Emilyn Tan, Linda H L Lua, et al.
Methods (San Diego, Calif.)
|
May 4, 2013
Virus-like particle formulation optimization by miniaturized high-throughput screening
Johannes Mohr, Yap P Chuan, Yang Wu, et al.
Vaccine
|
April 16, 2018
Vaccine Technology VI: Innovative and integrated approaches in vaccine development
Laura A Palomares, Tarit K Mukhopadhyay, Yvonne Genzel, et al.
Vaccine
|
September 27, 2015
Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza
Nani Wibowo, Yang Wu, Yuanyuan Fan, et al.
Biotechnology Progress
|
July 12, 2022
Design and optimization of membrane chromatography for monoclonal antibody charge variant separation
Sathish Nadar, Balaji Somasundaram, Marcela Charry, et al.
Vaccine
|
May 6, 2014
Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation
Nani Wibowo, Yap P Chuan, Arjun Seth, et al.
Biotechnology and Bioengineering
|
October 23, 2010
A new bioproduction route for a novel antimicrobial peptide
Derrick Kok Sing Tay, Gobinath Rajagopalan, Xiang Li, et al.
Chemico-Biological Interactions
|
September 2, 2024
Effective parallel evaluation of molecular design, expression and bioactivity of novel recombinant butyrylcholinesterase medical countermeasures
Joanne L Allard, Miguel Aguirre, Ruchi Gupta, et al.
Experimental & Applied Acarology
|
July 29, 2017
Evaluation of three adjuvants with respect to both adverse effects and the efficacy of antibody production to the Bm86 protein
Julie Petermann, Romain Bonnefond, Isabelle Mermoud, et al.
Page
of 5